Feindt v. United States

District Court, D. Hawaii·Decided April 9, 2024·No. 1:22-cv-00397·Unknown

Opinion

UNITED STATES DISTRICT COURT

DISTRICT OF HAWAII

PATRICK FEINDT, JR., et al., CIV. NO. 22-00397 LEK-KJM

Plaintiffs,

vs.

UNITED STATES OF AMERICA,

Defendant.

ORDER GRANTING IN PART AND DENYING IN PART DEFENDANT’S MOTION TO EXCLUDE THE EXPERT REPORT AND TESTIMONY OF DR. STEVEN BIRD, [FILED 1/16/24 (DKT. NO. 234)]

Defendant United States of America (“Defendant” or “United States”) files the instant motion seeking to exclude the expert report and opinion testimony of Steven Bird, M.D. (“Dr. Bird”), an expert witness designated by Plaintiffs, because it contends that Dr. Bird’s opinions regarding general and specific causation for Plaintiffs’ injuries, and Plaintiffs’ need for future medical monitoring are not the result of reliable and accepted methods, and that Dr. Bird’s report fails to contain a complete statement of his opinions as required by Federal Rule of Civil Procedure 26(a)(2)(B). See Def.’s Motion to Exclude the Expert Report and Testimony of Dr. Steven Bird, filed 1/16/24 (dkt. no. 234) (“Motion”). Plaintiffs filled their Opposition to the Motion to Exclude (“Mem. in Opp.”) on February 5, 2024, and Defendant filed its reply on February 12, 2024. [Dkt. nos. 264, 270.] These matters came for a hearing on February 22, 2024. On February 26, 2024, the Court issued an entering order informing the parties of its summary ruling granting in part and denying in part Defendant’s Motion to Exclude the

Expert Report and Testimony of Dr. Steven Bird, among other things. [Dkt. no. 282.] This Order supersedes that entering order. The Motion is granted in part and denied in part as set forth more fully below. In short, the Motion is granted as to Dr. Bird’s opinions regarding causation of long-term adverse effects from JP-5 exposure, future care needs and medical surveillance, Plaintiffs’ reasonable fear of significant long- term effects from JP-5 exposure, and insofar as Dr. Bird’s opinions regarding specific causation of short-term injuries from JP-5 exposure are based exclusively on animal studies. The Motion is denied in all other respects. BACKGROUND

The parties are familiar with the facts of this case and the Court will not repeat them here, except as relevant to the issues at hand. Briefly, this case arises out of the May 6 and November 20, 2021 fuel leaks from the United States Navy’s (“the Navy”) Red Hill Bulk Fuel Storage Facility on Joint Base Pearl Harbor-Hickam (“Red Hill” and “JBPHH”). [Fifth Amended Complaint, filed 12/1/23 (dkt. no. 210), at pgs. iii, 1; ¶¶ 4, 9.] Plaintiffs allege that Defendant owns and operates Red Hill and the water system that serves JBPHH, as well as the housing that Plaintiffs lease and reside upon. [Id. at ¶¶ 6, 9, 530.] Defendant was allegedly negligent in releasing fuel into the water supply, among other things. [Id. at ¶¶ 4, 467, 481.]

Plaintiffs allege that they suffered health issues, economic harm and fear as a result of the spills and their aftermath. Plaintiffs allege they are at increased risk of future medical conditions due to their exposure to contaminated water, and require medical monitoring. [Id. at ¶¶ 82-86.] Plaintiffs seek damages for past and future: pain and suffering, emotional distress, medical expenses, loss of income and earning capacity, physical impairment, loss of enjoyment and quality of life; as well as increased risk of future harm and medical monitoring for life, and loss of life expectancy, among other things. [Id. at pgs. 190-91.] Dr. Bird submitted an expert report, which stated his

opinions as well as his educational background and professional experience in the field of medical toxicology. [Defendant’s Notice of Filing Exhibits A and B, in Support of Its Local Rule 56.1 Concise Statement of Facts [ECF Nos. 205-1, 205-2], filed 2/12/24 (dkt. no. 272) (“Refiled Summary Judgment Exhibits”), Exh. A (report by Dr. Bird, dated 7/24/23) (“Bird Report”); see also Motion, Decl. of Caroline W. Stanton (“Stanton Decl.”) at ¶ 2 (noting the Bird Report is cited as Exhibit A in support of the Motion). Dr. Bird summarized his opinions: 1. Based on data detailed below, individuals on the water line, including the Plaintiffs’ [sic], were exposed to water contaminated with [jet propulsion 5 jet fuel (“JP-5”)] via three routes: dermal, inhalation, and ingestion.

2. The dose and duration of JP-5 were sufficient to cause acute and long-term injuries.

3. Studies support that acute symptoms of JP-5 exposure would include skin irritation and rash; abdominal pain; vomiting; diarrhea; headache; brain “fogginess”; irregular menstrual cycles; fatigue; anxiety; and other protean neurological symptoms. These symptoms are consistent with what the CDC and government provides sic are expected symptoms from such exposure. Most of the Plaintiff experienced many of these symptoms soon after the water became contaminated.

4. Studies support that exposure to jet fuel can result in long term health effects to various organ systems, including the neurologic, gastrointestinal, hematologic, dermal, immune, renal, hepatic, endocrine, psychiatric, and reproductive/developmental systems.

5. Many of the Plaintiffs are or have experienced long term effects from the JP-5 exposure, including abdominal pain; headaches; tremors; fatigue; rashes; abnormal menstrual cycles; anxiety; and fear. 6. Studies suggest that exposure to jet fuel may result in latent effects, especially for individuals exposed in utero or as children, including behavioral, psychiatric, renal, pulmonary, dermal, immunologic, as well as cancer.

7. Individuals on the water line, including Plaintiffs, have a reasonable fear of significant long term effects from their exposure to jet fuel-contaminated water.

8. There is a need for medical surveillance of exposed individuals, including year [sic] medical evaluations and testing. If abnormalities in the physical exam, blood testing, or new complaints develop, then other more advanced testing would be indicated. [Bird Report at 5-6.] STANDARD Federal Rule of Evidence 702 provides that expert opinion evidence is admissible if: (1) the witness is sufficiently “qualified as an expert by knowledge, skill, experience, training, or education”; (2) the witness’s “scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue”; (3) the witness’s “testimony is based on sufficient facts or data”; (4) the witness’s “testimony is the product of reliable principles and methods”; and (5) the witness has reliably applied the relevant principles and methods to the facts of the case. Fed. R. Evid. 702. Under Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) (“Daubert I”), a trial judge is required to apply a gatekeeping role to expert witness testimony. White v. Ford Motor Co., 312 F.3d 998, 1007 (9th Cir. 2002), opinion amended on denial of reh’g, 335 F.3d 833 (9th Cir. 2003). The Rule 702 inquiry under Daubert I, however, “‘is a flexible one,’ and the ‘factors identified in

Free access — add to your briefcase to read the full text and ask questions with AI

Feindt v. United States, (D. Haw. 2024).

Feindt v. United States (Feindt v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Primiano v. Cook
598 F.3d 558 (Ninth Circuit, 2010)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
United States v. Zebuel Jackson Hanna
293 F.3d 1080 (Ninth Circuit, 2002)
United States v. Richard Joseph Finley
301 F.3d 1000 (Ninth Circuit, 2002)
United States v. Eduardo Sandoval-Mendoza
472 F.3d 645 (Ninth Circuit, 2006)
Campbell v. ANIMAL QUARANTINE STATION, ETC.
632 P.2d 1066 (Hawaii Supreme Court, 1981)
Henricksen v. ConocoPhillips Co.
605 F. Supp. 2d 1142 (E.D. Washington, 2009)
In Re Silicone Gel Breast Impl. Prod. Liab. Lit.
318 F. Supp. 2d 879 (C.D. California, 2004)
Stephen Wendell v. Glaxosmithkline LLC
858 F.3d 1227 (Ninth Circuit, 2017)
O'Grady v. State.
398 P.3d 625 (Hawaii Supreme Court, 2017)
United States v. Edwin Flores
901 F.3d 1150 (Ninth Circuit, 2018)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
43 F.3d 1311 (Ninth Circuit, 1995)
In re Roundup Prods. Liab. Litig.
390 F. Supp. 3d 1102 (N.D. California, 2018)
Clausen v. M/V New Carissa
339 F.3d 1049 (Ninth Circuit, 2003)